brivaracetam Injection 10 mg/ml - 5 ml
Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Comments
Ref. product: Briviact® UCB
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years.
Main therapeutic areas include diabetes, CNL, dermatology, and oncology.
Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments.
The company possesses 10+ manufacturing facilities that are cGMP-compliant.
Manufacturer usually replies in 20 days